201 related articles for article (PubMed ID: 8756625)
41. Class II MHC transcriptional mutants are defective in higher order complex formation.
Riley JL; Boss JM
J Immunol; 1993 Dec; 151(12):6942-53. PubMed ID: 8258702
[TBL] [Abstract][Full Text] [Related]
42. Repression of major histocompatibility complex I-A beta gene expression by dbpA and dbpB (mYB-1) proteins.
Lloberas J; Maki RA; Celada A
Mol Cell Biol; 1995 Sep; 15(9):5092-9. PubMed ID: 7651426
[TBL] [Abstract][Full Text] [Related]
43. A novel cysteine-rich sequence-specific DNA-binding protein interacts with the conserved X-box motif of the human major histocompatibility complex class II genes via a repeated Cys-His domain and functions as a transcriptional repressor.
Song Z; Krishna S; Thanos D; Strominger JL; Ono SJ
J Exp Med; 1994 Nov; 180(5):1763-74. PubMed ID: 7964459
[TBL] [Abstract][Full Text] [Related]
44. Major histocompatibility complex class II-associated invariant chain gene expression is up-regulated by cooperative interactions of Sp1 and NF-Y.
Wright KL; Moore TL; Vilen BJ; Brown AM; Ting JP
J Biol Chem; 1995 Sep; 270(36):20978-86. PubMed ID: 7673122
[TBL] [Abstract][Full Text] [Related]
45. The same CCAAT box-binding factor binds to the promoter of two coordinately regulated major histocompatibility complex class II genes.
Kern MJ; Woodward JG
Mol Cell Biol; 1991 Jan; 11(1):578-81. PubMed ID: 1986250
[TBL] [Abstract][Full Text] [Related]
46. A new member of the leucine zipper class of proteins that binds to the HLA DR alpha promoter.
Liou HC; Boothby MR; Finn PW; Davidon R; Nabavi N; Zeleznik-Le NJ; Ting JP; Glimcher LH
Science; 1990 Mar; 247(4950):1581-4. PubMed ID: 2321018
[TBL] [Abstract][Full Text] [Related]
47. Regulation of major histocompatibility class II gene expression in FRTL-5 thyrocytes: opposite effects of interferon and methimazole.
Montani V; Shong M; Taniguchi SI; Suzuki K; Giuliani C; Napolitano G; Saito J; Saji M; Fiorentino B; Reimold AM; Singer DS; Kohn LD
Endocrinology; 1998 Jan; 139(1):290-302. PubMed ID: 9421427
[TBL] [Abstract][Full Text] [Related]
48. Assembly of the RFX complex on the MHCII promoter: role of RFXAP and RFXB in relieving autoinhibition of RFX5.
Garvie CW; Boss JM
Biochim Biophys Acta; 2008 Dec; 1779(12):797-804. PubMed ID: 18723135
[TBL] [Abstract][Full Text] [Related]
49. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5.
Scholl T; Mahanta SK; Strominger JL
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6330-4. PubMed ID: 9177217
[TBL] [Abstract][Full Text] [Related]
50. Class II box consensus sequences in the HLA-DR alpha gene: transcriptional function and interaction with nuclear proteins.
Sherman PA; Basta PV; Moore TL; Brown AM; Ting JP
Mol Cell Biol; 1989 Jan; 9(1):50-6. PubMed ID: 2538724
[TBL] [Abstract][Full Text] [Related]
51. CREB and phospho-CREB interact with RFX5 and CIITA to regulate MHC class II genes.
Lochamy J; Rogers EM; Boss JM
Mol Immunol; 2007 Feb; 44(5):837-47. PubMed ID: 16730065
[TBL] [Abstract][Full Text] [Related]
52. A hierarchy of nuclear localization signals governs the import of the regulatory factor X complex subunits and MHC class II expression.
Nagarajan UM; Long AB; Harreman MT; Corbett AH; Boss JM
J Immunol; 2004 Jul; 173(1):410-9. PubMed ID: 15210800
[TBL] [Abstract][Full Text] [Related]
53. Tumor necrosis factor alpha response elements in the HLA-DRA promoter: identification of a tumor necrosis factor alpha-induced DNA-protein complex in astrocytes.
Panek RB; Moses H; Ting JP; Benveniste EN
Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11518-22. PubMed ID: 1454841
[TBL] [Abstract][Full Text] [Related]
54. Protease treatment of nuclear extracts distinguishes between class II MHC X1 box DNA-binding proteins in wild-type and class II-deficient B cells.
Hasegawa SL; Riley JL; Sloan JH; Boss JM
J Immunol; 1993 Mar; 150(5):1781-93. PubMed ID: 8436816
[TBL] [Abstract][Full Text] [Related]
55. Mutually exclusive binding of two cellular factors within a critical promoter region of the gene for the IE110k protein of herpes simplex virus.
O'Rourke D; O'Hare P
J Virol; 1993 Dec; 67(12):7201-14. PubMed ID: 8230442
[TBL] [Abstract][Full Text] [Related]
56. An ATF/CREB binding motif is required for aberrant constitutive expression of the MHC class II DR alpha promoter and activation by SV40 T-antigen.
Cox PM; Goding CR
Nucleic Acids Res; 1992 Sep; 20(18):4881-7. PubMed ID: 1329030
[TBL] [Abstract][Full Text] [Related]
57. Physical and functional interaction between the human T-cell lymphotropic virus type 1 Tax1 protein and the CCAAT binding protein NF-Y.
Pise-Masison CA; Dittmer J; Clemens KE; Brady JN
Mol Cell Biol; 1997 Mar; 17(3):1236-43. PubMed ID: 9032250
[TBL] [Abstract][Full Text] [Related]
58. Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction.
Chin KC; Mao C; Skinner C; Riley JL; Wright KL; Moreno CS; Stark GR; Boss JM; Ting JP
Immunity; 1994 Nov; 1(8):687-97. PubMed ID: 7600294
[TBL] [Abstract][Full Text] [Related]
59. Role of the X2 box in activated transcription from the DRA promoter in B cells.
Setterblad N; Peterlin BM; Andersson G
Immunogenetics; 1997; 46(4):318-25. PubMed ID: 9218534
[TBL] [Abstract][Full Text] [Related]
60. Regulatory factor-X binding to mutant HLA-DRA promoter sequences.
Hasegawa SL; Sloan JH; Reith W; Mach B; Boss JM
Nucleic Acids Res; 1991 Mar; 19(6):1243-9. PubMed ID: 1903200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
